Literature DB >> 7677478

Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass.

P G Jansen1, H te Velthuis, E R Bulder, R Paulus, M R Scheltinga, L Eijsman, C R Wildevuur.   

Abstract

BACKGROUND: A hyperdynamic response to cardiopulmonary bypass is characteristically observed in the post-operative course. To determine the effect of prime volume on the hemodynamic response, a database study was performed on patients who underwent elective coronary artery bypass grafting with an extracorporeal circuit with either a large prime volume (2,350-mL prime, n = 20) or a small prime volume (1,400-mL prime, n = 20).
METHODS: Measurements were carried out at fixed time points before and after cardiopulmonary bypass (until 18 hours postoperatively) and include hematocrit, colloid oncotic pressure, fluid balance, and hemodynamic profile (mean of three measurements).
RESULTS: The lower colloid oncotic pressure in the large prime group (16.2 +/- 0.6 mm Hg versus 19.1 +/- 1.1 mm Hg, p = 0.0002) was associated with a highly positive fluid balance (5.5 +/- 0.9 L versus 2.8 +/- 0.7 L, p = 0.0001). With the on-bypass hematocrit aimed at 22% to 23%, autologous blood was predonated by 16 patients in the small prime group but by none in the large prime group. Reinfusion of autologous blood resulted in a reduction in blood bank requirements (p = 0.03). Mean arterial pressure was 83 +/- 4 mm Hg for small prime versus 76 +/- 4 mm Hg for large prime (p = 0.01). Cardiac index was 2.9 +/- 0.2 L.min-1.m-2 for small prime versus 3.8 +/- 0.3 L.min-1.m-2 for large prime (p = 0.0001). Pulmonary vascular resistance index was 281 +/- 40 dyne.s.cm5.m-2 for small prime versus 188 +/- 22 dyne.s.cm5.m-2 for large prime (p = 0.0009). Oxygen delivery was 42 +/- 5 mL.min-1.m-2 for small prime versus 51 +/- 3 mL.min-1.m-2 for large prime (p = 0.004). Vasoactive medication was not different among groups.
CONCLUSIONS: Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass. Furthermore, an important reduction in blood bank products can be obtained with small prime volumes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677478     DOI: 10.1016/0003-4975(95)00385-X

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Early in vivo experience with the pediatric continuous-flow total artificial heart.

Authors:  Jamshid H Karimov; David J Horvath; Nicole Byram; Gengo Sunagawa; Barry D Kuban; Shengqiang Gao; Raymond Dessoffy; Kiyotaka Fukamachi
Journal:  J Heart Lung Transplant       Date:  2018-03-30       Impact factor: 10.247

2.  Low-Resistance, Concentric-Gated Pediatric Artificial Lung for End-Stage Lung Failure.

Authors:  Alex J Thompson; Skylar Buchan; Benjamin Carr; Clinton Poling; McKenzie Hayes; Uditha Piyumindri Fernando; Andreas Kaesler; Peter Schlanstein; Felix Hesselmann; Jutta Arens; Joseph A Potkay; Alvaro Rojas-PeÑa; Robert H Bartlett; Ronald B Hirschl
Journal:  ASAIO J       Date:  2020-04       Impact factor: 3.826

Review 3.  Vitamin C to Improve Organ Dysfunction in Cardiac Surgery Patients-Review and Pragmatic Approach.

Authors:  Aileen Hill; Sebastian Wendt; Carina Benstoem; Christina Neubauer; Patrick Meybohm; Pascal Langlois; Neill Kj Adhikari; Daren K Heyland; Christian Stoppe
Journal:  Nutrients       Date:  2018-07-27       Impact factor: 5.717

4.  Effects of crystalloid and colloid priming strategies for cardiopulmonary bypass on colloid oncotic pressure and haemostasis: a meta-analysis.

Authors:  Anne Maria Beukers; Jamy Adriana Catharina de Ruijter; Stephan Alexander Loer; Alexander Vonk; Carolien Suzanna Enna Bulte
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03

Review 5.  Current Evidence about Nutrition Support in Cardiac Surgery Patients-What Do We Know?

Authors:  Aileen Hill; Ekaterina Nesterova; Vladimir Lomivorotov; Sergey Efremov; Andreas Goetzenich; Carina Benstoem; Mikhail Zamyatin; Michael Chourdakis; Daren Heyland; Christian Stoppe
Journal:  Nutrients       Date:  2018-05-11       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.